Transfection is the process by which nucleic acids are introduced into eukaryotic cells. Protocols and techniques vary widely and include lipid transfection and chemical and physical methods such as electroporation. Expertise in cellular and molecular biology is behind the Invitrogen product portfolio, which are the most cited and trusted transfection and selection systems available.
Use this overview of our most effective transfection products to choose the solution that’s right for you.
Transfection products
By sample type
By cell type
Our protocols for Lipofectamine Reagent have been optimized for efficiency, viability, and reproducibility across a broad range of cell types. This is often the best place to start, especially with a new cell line.
If you are working with cancer cell lines, we’ve developed and validated cancer cell line-specific protocols covering the most researched cell lines in breast cancer, lung cancer, and liver cancer.
If neither of these options is working for your specific cell type, consult our additional cell type–specific protocols for further optimization.
Transfection reagents
Designed for effective and efficient nucleic acid delivery into both traditional and difficult-to-transfect cell lines and for transient transfection in suspension cultures. Lister below are Invitrogen product lines:
- Lipofectamine 3000
- Lipofectamine Stem
- Lipofectamine CRISPRMAX
- Invivofectamine 3.0
- Lipofectamine MessengerMAX
- Lipofectamine RNAiMAX
- Lipofectamine 2000
Compare Lipofectamine reagents ›
View all transfection reagents ›
One Cell Bio product handbook
We have simplified our portfolio to show you how our most popular products and services are used as single tools or integrated system solutions. This handbook is meant to expedite your search for the right cell biology product and give you an in-depth look at how we can help accelerate research.
Resources
Education & tools
Related applications
Transfection protocols
Related products
For Research Use Only. Not for use in diagnostic procedures.
